Table 3.
TVRR according to Patient Characteristics and Pathological Results
| Characteristics/Index | Number (%) | TVRR | P Value |
|---|---|---|---|
| Gender | 0.283 | ||
| Male | 55 (68.8%) | 47.2±22.7 | |
| Female | 25 (31.2%) | 53.7±26.1 | |
| Age | 0.318 | ||
| ≤60 | 50 (62.5%) | 53.9±23.3 | |
| >60 | 30 (37.5%) | 48.0±27.9 | |
| Tumor Distance From Anal Verge | 0.445 | ||
| ≤5cm | 31 (38.8%) | 54.4±25.3 | |
| >5cm | 49 (61.2%) | 50.0±25.1 | |
| Differentiation | 0.040 | ||
| Well/Moderate | 74 (92.5%) | 53.3±23.9 | |
| Poor/mucinous adenocarcinoma | 6 (7.5%) | 31.5±33.3 | |
| Serum CEA | 0.394 | ||
| ≤5 ng/ml | 62 (77.5%) | 53.0±24.4 | |
| >5 ng/ml | 18 (22.5%) | 47.2±27.8 | |
| cT Stage | 0.617 | ||
| cT2-3 | 74 (92.5%) | 51.3±25.6 | |
| cT4 | 6 (7.5%) | 56.6±14.7 | |
| cN Stage | 0.859 | ||
| cN- | 27 (33.8%) | 52.4±25.7 | |
| cN+ | 53 (66.2%) | 51.3±25.0 | |
| cTNM Stage | 0.859 | ||
| II | 27 (33.8%) | 52.4±25.7 | |
| III | 53 (66.2%) | 51.3±25.0 | |
| pT Stage | 0.001 | ||
| pT0-2 | 28 (35.0%) | 64.7±21.0 | |
| pT3-4 | 52 (65.0%) | 45.2±24.9 | |
| pN Stage | 0.063 | ||
| pN- | 61 (76.3%) | 54.6±23.3 | |
| pN+ | 19 (23.7%) | 42.3±28.9 | |
| pTNM Stage | <0.001 | ||
| pCR/I Stage | 25 (31.3%) | 66.3±16.5 | |
| II/III Stage | 55 (68.7%) | 45.0±25.7 | |
| Lymphovascular Invasion | 0.056 | ||
| Yes | 3 (3.8%) | 24.6±34.4 | |
| No | 77 (96.2%) | 52.7±24.4 | |
| Perineural Invasion | 0.564 | ||
| Yes | 9 (11.3%) | 47.0±10.6 | |
| No | 71 (88.7%) | 52.3±26.4 | |
| Extra Nodal Tumor Deposits | 0.416 | ||
| Yes | 9 (11.3%) | 45.2±27.9 | |
| No | 71 (88.7%) | 52.5±24.9 | |
| CRM | NA | ||
| ≤1mm | 1 (1.3%) | -31.7 | |
| >1mm | 79 (98.7%) | 52.7±23.4 |